首页 正文

A therapeutic patent overview of MDM2/X-targeted therapies (2014-2018)

{{output}}
Introduction: MDM2 and MDMX proteins provide the inhibition of p53 tumor suppressor, thus allowing for accelerated mutation-driven cancer microevolution. A pharmacological blockade of MDM2/X-p53 interaction results in p53 reactiv... ...